Onkos Surgical raised $15 million in Series C funding from its existing investor syndicate.
Proceeds will drive revenue growth by accelerating the company’s research and development pipeline, expanding its commercial footprint and evolving manufacturing capabilities. These investments support the company’s focus on delivering surgeon-driven and patient-inspired approaches to address three main clinical challenges of complex orthopedic procedures – implant loosening, soft tissue failures and infection.
More than 350 medical institutions in the U.S. choose Onkos’ innovative Precision Orthopaedics solutions. This approach supports improved patient outcomes and experiences, leveraging the latest innovations in virtual surgical planning, 3D anatomic modeling and printing, implant design and workflow optimization.
Onkos Surgical raised $15 million in Series C funding from its existing investor syndicate.
Proceeds will drive revenue growth by accelerating the company's research and development pipeline, expanding its commercial footprint and evolving manufacturing capabilities. These investments support the company's focus on delivering surgeon-driven...
Onkos Surgical raised $15 million in Series C funding from its existing investor syndicate.
Proceeds will drive revenue growth by accelerating the company’s research and development pipeline, expanding its commercial footprint and evolving manufacturing capabilities. These investments support the company’s focus on delivering surgeon-driven and patient-inspired approaches to address three main clinical challenges of complex orthopedic procedures – implant loosening, soft tissue failures and infection.
More than 350 medical institutions in the U.S. choose Onkos’ innovative Precision Orthopaedics solutions. This approach supports improved patient outcomes and experiences, leveraging the latest innovations in virtual surgical planning, 3D anatomic modeling and printing, implant design and workflow optimization.
Copy to clipboard 
